We target complex drugs with limited competition

Rajesh Jain, joint managing director of Panacea Biotec, the second-largest vaccine maker in the country, talks about the company's plans to diversify into hospital business in an interview with Soma Das. He also talks about the significance of the Indian drug regulatory system passing the World Health Organisation audit. Edited excerpts:

The Indian drug regulator has just passed the WHO audit. What does this mean for the R19,000-crore domestic vaccine industry?

It is a great development for the drug regulator as well as the industry. It demonstrates the commitment of India to produce drugs of high quality at affordable prices. It marks a radical turning point. It was only a few years back that the drug regulator had failed the WHO inspection. It was unfortunate and actually threatened the vaccine exports from the country, which were on the verge of being banned on the pretext of our regulations being weak. So it comes as a reassurance to the global community on the quality of drugs being produced in India. This is particularly significant as India is already source to around 70% of vaccines in the developing countries (in volume terms). The Drug Controller General of India can now guide many of the regulators in other developing markets, specially neighbouring countries that have embarked on the path of strengthening their drug regulatory frameworks.

Could you give the specifics of the latest polio vaccine order that you bagged from the government?

Our company has got government orders for supply of 345 million doses of Trivalent oral polio vaccines and bivalent oral polio vaccine of over R187 crore to be supplied during the period December 2012 till May 2013 to meet the requirements of national immunisation days and supplementary national immunisation days. Of this, 80% would be shipped over next three months and orders worth R167 crore should be supplied by February.

... contd.

Please read our terms of use before posting comments
TERMS OF USE: The views expressed in comments published on indianexpress.com are those of the comment writer's alone. They do not represent the views or opinions of The Indian Express Group or its staff. Comments are automatically posted live; however, indianexpress.com reserves the right to take it down at any time. We also reserve the right not to publish comments that are abusive, obscene, inflammatory, derogatory or defamatory.